临床病理特征

LVSI阴性

LVSI阳性

χ²

P

年龄

54.16 ± 9.07

59.14 ± 8.73

-

<0.001^*

BMI (kg/m²)

25.7 ± 4.61

26.1 ± 5.6

-

0.165

高血压

无

203 (75.7%)

65 (24.3%)

4.459

0.035^*

有

104 (66.2%)

53 (33.8%)

糖尿病

无

262 (73.4%)

95 (26.6%)

1.482

0.224

有

45 (66.2%)

23 (33.8%)

子宫腺肌病

无

268 (71.8%)

105 (28.2%)

0.226

0.635

有

39 (75.0%)

13 (25.0%)

子宫肌瘤

无

191 (73.5%)

69 (26.5%)

0.502

0.479

有

116 (70.3%)

49 (29.7%)

绝经状态

否

137 (73.5%)

31 (26.5%)

12.013

<0.001^*

是

170 (70.3%)

87 (29.7%)

恶性肿瘤家族史

否

243 (71.9%)

95 (28.1%)

0.096

0.756

是

64 (73.6%)

23 (26.4%)

CA-125 (U/ml)

<35

263 (76.7%)

80 (23.3%)

17.483

<0.001^*

≥35

44 (53.7%)

38 (46.3%)

肌层浸润深度

<1/2

285 (80.5%)

69 (19.5%)

72.316

<0.001^*

≥1/2

22 (31.0%)

49 (69.0%)

病理类型

子宫内膜样腺癌

302 (76.8%)

91 (23.2%)

55.296

<0.001^*

非子宫内膜样腺癌

5 (15.6%)

27 (84.4%)

组织学分级

G1或G2

280 (79.5%)

72 (20.5%)

54.603

<0.001^*

G3

27 (37.0%)

46 (63%)

WBC (^*10⁹/L)

5.53 ± 2.18

5.81 ± 2.23

-

0.075

NE (^*10⁹/L)

3.27 ± 1.65

3.48 ± 1.77

-

0.196

LYM (^*10⁹/L)

1.69 ± 0.66

1.82 ± 0.79

-

0.021^*

PLT (^*10⁹/L)

272.5 ± 100

262 ± 98

-

0.323

NLR

1.90 ± 1.09

1.90 ± 1.06

-

0.087

PLR

163.86 ± 67.16

142.39 ± 52.77

0.007^*

RBC (^*10¹²/L)

4.36 ± 0.48

4.36 ± 0.46

-

0.936

HGB (g/L)

132 ± 19

131.5 ± 21

-

0.817